Lianxin Liu
University of Science and Technology of China(CN)Harbin Medical University(CN)Anhui Provincial Hospital(CN)First Affiliated Hospital of Harbin Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer, Hypoxia, and Metabolism, Cancer-related molecular mechanisms research, RNA modifications and cancer, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Tumour-associated mutant p53 drives the Warburg effect(2013)429 cited
- → Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma(2013)293 cited
- → Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation(2018)263 cited
- → Role of microRNA in anticancer drug resistance(2009)233 cited
- → Laparoscopic Versus Open Nephroureterectomy for the Treatment of Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Cumulative Analysis of Comparative Studies(2012)194 cited
- → Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma(2018)141 cited